DESKi closes $6M seed to expand AI in early disease detection

Bordeaux-based healthtech startup DESKi has closed a $6 million seed round. The round was led by Racine² (Serena & makesense), with BNP Paribas Développement, Épopée Gestion, Good Only Ventures, Better Angle, and NACo participating.

The funds will support DESKi’s U.S. and European market launch.

DESKI was founded by brothers Bertrand and Olivier Moal, who’ve developed HeartFocus, the first AI-powered cardiac ultrasound tool that enables even first-time users to capture diagnostic-quality heart scans.

FDA-cleared and backed by clinical studies, HeartFocus is redefining early detection in cardiology with a simple conviction: No heart can wait™.

Heart disease remains the leading cause of death worldwide, yet access to echocardiography is limited by a shortage of specialists.

HeartFocus bridges this gap with real-time AI guidance that empowers any healthcare worker to perform scans after just a few hours of training, even in remote or primary care settings. Built by experts in medicine and engineering, HeartFocus by DESKi is powered by proprietary AI trained on over 10 million data points.

Already recognised by the French Ministry of Health (France 2030 award), it integrates seamlessly into global care platforms and delivers high-impact, scalable diagnostics.

As healthcare systems face growing pressure, HeartFocus offers a critical missing link in cardiac care: a scalable, accessible diagnostic tool for all. 
This seed round moves DESKi from clinical proof to large-scale deployment, with global implications for patient care and early disease prevention.

Lead image: DESKi